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The efficiency of an embryo bank depends on provision of optimal conditions for 19 
recovery, cryopreservation and transfer to a breed or strain. In this sense, increasing the 20 
number of embryos available using superovulation should improve the cryobank 21 
efficiency. However, vagueness of response to conventional protocols to control or 22 
increase ovarian response and the quality of oocytes and embryos and their 23 
cryotolerance remain a challenge. The aim of our study was to evaluate the effect of 24 
corifollitropin alpha (CTP) and a recombinant human FSH (rhFSH), alone or 25 
supplemented with rhLH, on embryo cryosurvival by in vitro development and OCT4 26 
and NANOG mRNA abundance at blastocyst stage and offspring rate. In vitro 27 
development of vitrified embryos was not significantly affected by superstimulation 28 
with or without rhLH supplementation, resulting in similar development rates to those 29 
of the control groups (fresh and vitrified embryos from non-superstimulated donor 30 
does). Blastocysts developed from vitrified embryos showed higher levels of OCT4 31 
transcript abundance than fresh control, while NANOG transcript abundance was only 32 
higher in the blastocysts developed from vitrified embryos after superstimulation 33 
treatment in comparison with control groups. The implantation and offspring rates at 34 
birth were negatively affected by supplementation with rhLH. Both rhFSH or CTP 35 
vitrified embryo groups showed an implantation rate similar to those of the control 36 
groups, but an offspring rate lower than control. In conclusion, embryos produced using 37 
corifollitropin alpha did not compromise the cryosurvival of vitrified embryos in the 38 
rabbit. In addition, this study points out the negative effect of rhLH supplementation in 39 
terms of offspring rate on embryo vitrification. 40 
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Embryo cryopreservation provides an important tool for animal breeding, enabling the 44 
establishment of genome cryobanking and saving embryos for an unlimited time. The 45 
efficiency of an embryo bank depends on the provision of optimal conditions for 46 
recovery, cryopreservation and transfer for each breed or strain. To this end, different 47 
laboratories have successfully developed embryo banks for a reduced number of breeds 48 
or strains (main laboratory and livestock species). In this sense, increasing the number 49 
of embryos using superovulation treatment will clearly reduce the number of donors, 50 
improve the efficiency of animal production (Takeo and Nagata, 2015) and minimise the 51 
number of animals in line with the 3Rs principle concept (Russell, 2005). Nevertheless, 52 
controlling reproductive events in unusual species or breeds remains a challenge, given 53 
the vagueness of response to conventional protocols to control or increase ovarian 54 
response and the quality of obtained oocytes and embryos and their cryotolerance in 55 
breeds or strains.  56 
In rabbits, to ensure the maximum number of normal embryos recovered per donor, both 57 
eCG and pituitary derived FSH have commonly been used to induce superovulation 58 
(Kanayama et al. 1994, Kauffman et al. 1998, Hashimoto et al. 2004, Mehaisen et al. 59 
2005, 2006, Salvetti et al. 2007). However, superovulation treatments may generate a 60 
higher number of abnormal and immature follicles through either increasing the 61 
cytogenetic defects or abnormal steroidogenesis pattern, affecting the oocyte 62 
competence and consequently the future embryo development (Kennelly and Foote 63 
1965, Fechheimer and Beatty 1974, Paufler et al. 1975, Taneja et al. 1990, Schmidt et 64 
al. 1992, Cheng et al. 1999, Hashimoto et al. 2004; Cortell et al. 2015).  65 
Specifically, both oocytes and embryos obtained after FSH treatments seem to have 66 
advantages in terms of number and quality versus eCG, but due to the relatively short 67 
elimination half-life of FSH and rapid metabolic clearance, two daily injections are 68 
required to maintain the threshold level during ovarian superstimulation.  Recently, 69 
recombinant human FSH (rhFSH) and a long-acting recombinant FSH named 70 
corifollitropin alpha (CTP) were successfully assayed in rabbit (Viudes-de-Castro et al. 71 
2015 and 2017). CTP has a plasma half-life of approximately 65 hours and an almost 72 
four-fold extended time to peak serum levels in a single injection (Duijkers et al. 2002, 73 
Devroey et al. 2004, 2009) and provides both good superovulatory response and similar 74 
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in vivo survival rate to non superovulated embryos, especially when CTP is 75 
supplemented with LH (Viudes-de-Castro et al., 2017). 76 
The use of LH in superovulation treatments is controversial and unclear; the quality of 77 
oocytes or embryos recovered after superovulation treatments varies, and one of the 78 
reasons for this may be the variable LH:FSH ratio. Low LH levels might intensify FSH 79 
sensitivity in granulosa cells by increasing androgen synthesis during the early stage of 80 
folliculogenesis, and this activity is required for normal follicle and oocyte development 81 
(Ruvolo et al. 2007, Durnerin et al. 2008). Moreover, high LH levels seem to be 82 
detrimental for follicular growth. In rabbits, the effect of LH on superovulation has been 83 
studied using purified porcine FSH, obtaining highly variable results (Hashimoto et al. 84 
2004, Salvetti et al. 2007). An LH concentration window has been suggested in women 85 
below which estradiol production is not adequate and above which LH may be 86 
detrimental to follicular development (Borini and Dal Prato 2005, Balasch and 87 
Fábregues 2006). Our studies with recombinant human gonadotropins suggested that in 88 
the rabbit, the window of LH is FSH dose dependent, and the higher the concentration 89 
of FSH used, the more the LH window shifts to higher concentrations. When the FSH 90 
concentration used is low, 10% of LH supplement may exceed the LH requirements and 91 
the fertilisation and embryonic development is negatively affected. In contrast, when the 92 
FSH concentration used is high, 10% of LH supplementation is essential to increase the 93 
number of follicles recruited during the selection phase (Viudes-de-Castro et al. 2015).  94 
Another concerning aspect is the negative interaction between superovulation and 95 
cryopreservation, making the embryos more sensitive to cryopreservation (Leoni et al. 96 
2001, Belinger et al. 2004, Mehaisen et al. 2006, Forcada et al. 2011) and decreasing 97 
their ability to produce offspring (Maurer et al. 1968, Carney and Foote 1990, Kauffman 98 
et al. 1998,  Mehaisen et al. 2006). Superovulated embryos seem to have a higher 99 
sensitivity to low temperatures and this leads to a decrease in their subsequent potential 100 
capacity for development after vitrification, based on a reduced number of trophoblastic 101 
cells and inner cell mass per embryo (Vajta 2000, and  Leoni et al. 2001). The surviving 102 
blastomeres after vitrification procedures may be insufficient in number to permit the 103 
re-expansion of the blastocoelic cavity and continue the physiological development.  104 
The aim of the current study was to evaluate the effect of corifollitropin alpha (CTP) 105 
and a recombinant human FSH (rhFSH), alone or supplemented with recombinant 106 
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human LH, on embryo cryosurvival by in vitro development and mRNA abundance of 107 
OCT4 and NANOG at blastocyst stage and live offspring rate at birth. 108 
 109 
MATERIALS AND METHODS  110 
All chemicals, unless otherwise stated, were reagent-grade and purchased from Sigma-111 
Aldrich Química S.A. (Alcobendas, Madrid, Spain). 112 
Animals and ethical statement  113 
The research was carried out at the experimental farm of the Institute of Science and 114 
Animal Technology (ICTA), Polytechnic University of Valencia. All the experimental 115 
procedures used in this study were performed in accordance with Directive 2010/63/EU 116 
EEC for animal experiments and reviewed and approved by the Ethical Committee for 117 
Experimentation with Animals of the Polytechnic University of Valencia, Spain 118 
(research code: 2015/VSC/PEA/00061).  119 
One hundred and twenty nulliparous does 18-20 weeks old were used. Does belonged to 120 
a New Zealand White line selected for litter size at weaning (Line A, Estany et al. 121 
1989). Animals were housed in flat-deck cages, fed with a standard pellet diet ad 122 
libitum and had free access to water. An alternating cycle of 16 h lights and 8 h of dark 123 
was used. 124 
Hormonal treatment 125 
Ovarian stimulation was induced using corifollitropin alpha (CTP, Elonva, Merck Sharp 126 
& Dohme S.A.; Spain) and recombinant human FSH (rhFSH, Gonal-F 75; Serono 127 
Europe Ltd., London, United Kingdom) either alone or in combination with 128 
recombinant human LH (rhLH, Luveris 75; Serono Europe Ltd., London, United 129 
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Kingdom). Rabbit donors, weighing 3.9 to 4.2 kg, were assigned randomly to five 130 
experimental groups: 131 
-Group CTP: 12 rabbit does were subcutaneously treated once with 3 µg of 132 
corifollitropin alpha. 133 
-Group CTP+rhLH: 12 rabbit does were subcutaneously treated once with 3 µg of 134 
corifollitropin alpha and intramuscularly treated with a 10% of recombinant human LH, 135 
distributed in five equal doses at 12-hour intervals. 136 
-Group rhFSH: 12 rabbit does were intramuscularly treated with 3 µg of recombinant 137 
human FSH, distributed in five equal doses at 12-hour intervals. 138 
-Group rhFSH+rhLH: 12 rabbit does were intramuscularly treated with 3 µg of 139 
recombinant human FSH in combination with a 10% of recombinant human LH, 140 
distributed in five equal doses at 12-hour intervals. 141 
-Group non-superovulated donor does: 36 receptive rabbit does without stimulation 142 
treatment were used to obtain fresh and vitrified embryos. Fresh embryos from non-143 
superovulated does were used as control. 144 
Superstimulated donor does were inseminated with 1 mL of sperm pool from fertile 145 
males of the same line 60 h after the first gonadotropin injection, and ovulation was 146 
induced with 1 µg buserelin acetate (Suprefact; Hoechst Marion Roussel, S.A., Madrid, 147 
Spain) given intramuscularly. Control group females were inseminated with the same 148 
sperm pool and ovulation was induced with 1 µg buserelin acetate. Sperm pool was 149 
constituted by 5-6 ejaculates from different males exhibiting a white colour and with a 150 
motility rate higher than 70% and morphological abnormality rate lower than 25%. The 151 
seminal dose used per donor doe was around 20-30 million sperm.   152 
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Embryo recovery 153 
Females were euthanised 72 h after artificial insemination with an intravenous injection 154 
of 0.6 g pentobarbital sodium (Dolethal; Vetoquinol, Madrid, Spain) and the 155 
reproductive tract was immediately removed. Embryos were recovered by perfusion of 156 
each oviduct and uterine horn with 10 mL Dulbecco’s phosphate buffered saline 157 
(HyClone™ DPBS liquid without Calcium, Magnesium, Phenol Red; HyClone 158 
Laboratories, Logan, Utah, USA) containing 0.2% bovine serum albumin 159 
(AMRESCO® Albumin Bovine, (BSA); Solon, USA), 0.133 g/L CaCl2, 0.100 g/L 160 
MgCl2 and antibiotics (100 IU/mL Penicillin and 0.01 mg/mL Streptomycin, Sigma-161 
Aldrich Quimica S.A., Spain). The recovered fluid was collected into sterile Petri dishes 162 
for examination under a stereomicroscope. Embryos were scored by morphologic 163 
criteria according to International Embryo Transfer Society classification (IETS). 164 
Briefly, only embryos in morula or early blastocyst stages with homogenous cellular 165 
mass and spherical mucin coat and zona pellucida were catalogued as normal embryos. 166 
In superstimulated groups, only embryos from donor does with more than 30 normal 167 
embryos were vitrified to avoid using non-superovulated embryos. Normal embryos 168 
from control group were split to immediately culture or transfer as fresh embryos or to 169 
vitrify. 170 
A total of 1061 normal embryos were used, 171 non-superovulated fresh embryos and 171 
890 as vitrified from different experimental groups.  172 
Embryo vitrification procedure 173 
Vitrification was carried out in 12 batches. A total of 890 embryos were vitrified and de-174 
vitrified using the methodology described by Vicente et al. (1999). The vitrification 175 
procedure was carried out in two steps at 20 °C. In the first step, embryos were placed 176 
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for 2 min in a vitrification solution consisting of 10% (v/v) dimethyl-sulphoxide (1.75M 177 
DMSO, Sigma) and 10% (v/v) ethylene glycol (2.23 M EG, Sigma) in DPBS 178 
supplemented with 0.2% (w/v) of BSA. In the second step, embryos were suspended for 179 
1 min in a solution of 20% (v/v) DMSO and 20% EG in DPBS supplemented with 0.2% 180 
(w/v) of BSA. Then, embryos suspended in the vitrification medium were loaded into 181 
0.25 ml plastic straws (IMV, L’Aigle, France) between two drops of DPBS separated by 182 
air bubbles. Finally, the straws were sealed and directly plunged into liquid nitrogen.  183 
De-vitrification procedure was performed by placing the French ministraws 10 cm from 184 
nitrogen vapour until the onset of ice formation in the vitrified fraction (milky 185 
appearance) and thawing by submerging the straws into a water bath at 20 °C for 10 sec. 186 
The vitrification medium was removed in two steps. In the first step, the embryos were 187 
expelled with the medium into a solution of DPBS with 0.33M sucrose for 5 min, and in 188 
the second step the embryos were washed in a DPBS solution for another 5 min. 189 
Devitrified embryos were scored and only undamaged embryos were catalogued as 190 
transferable. 191 
In vitro culture until blastocyst stage 192 
In vitro culture was performed in 6 batches. A total of 536 embryos were cultured for 48 193 
h in Tissue Culture Medium 199 (TCM199) + 10% Foetal Bovine Serum (FBS, Sigma-194 
Aldrich Quimica S.A., Spain) supplemented with antibiotics (100 IU/mL Penicillin and 195 
0.01 mg/mL Streptomycin, Sigma-Aldrich Quimica S.A., Spain) at 38.5 °C, 5% CO2 196 
and saturated humidity. The in vitro development ability of embryos to hatched state 197 
(more than 50% of mass cell extruded to zona pellucida, Figure 1) was recorded. 198 
 199 
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mRNA expression of OCT4 and NANOG genes. Extraction and quantitative PCR 200 
analysis 201 
PolyA RNA was extracted from pools consisting of 13 to 15 in vitro cultured embryos 202 
using the Dynabeads kit (Life Technologies, Carlsbad, CA, USA), following the 203 
manufacturer’s instructions. Four independent embryo pools were used for each 204 
experimental group. Then, reverse transcription was carried out using qScriptTMcDNA 205 
Synthesis kit (Quantabio, Beverly, MA, USA), according to the manufacturer’s 206 
instructions. Real-time polymerase chain reaction (PCR) reactions were conducted in an 207 
Applied Biosystems 7500 system (Applied Biosystems). Every PCR was performed 208 
from 5-mL diluted 1:10 complementary DNA (cDNA) template, 250-nM of forward and 209 
reverse specific primers (Table 1), and 15 mL of Power SYBR Green PCR Master Mix 210 
(Fermentas Gmbh, Madrid, Spain) in a final volume of 20 mL. The PCR protocol 211 
included an initial step of 50 °C (2 minutes), followed by 95 °C (10 minutes), and 42 212 
cycles of 95 °C (15 seconds) and 60 °C (30 seconds). After quantitative PCR, a melting 213 
curve analysis was performed by slowly increasing the temperature from 65 °C to 95 214 
°C, with continuous recording of changes in fluorescent emission intensity. The 215 
specificity was confirmed by melting curve analysis. 216 
Relative expression levels were calculated by 2-ΔΔCt method adjusted for PCR efficiency 217 
(Livak and Schmittgen, 2001), applying the geometric average of H2AFZ (H2A histone 218 
family member Z (Mamo et al. 2008) and GAPDH glyceraldehyde- 3-phosphate 219 
dehydrogenase (Llobat et al., 2012) as a housekeeping normalisation factor. Relative 220 
expression of cDNA pool from all samples was used as the calibrator to normalise all 221 
samples within one PCR run or between several runs. List of primers used for 222 
quantitative real-time polymerase chain reaction is shown in table 1. 223 
 224 
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Embryo transfer 225 
A total of 491 embryos were transferred into 36 recipient females induced to ovulate 72 226 
hours before transfer with 1 µg of buserelin acetate injected intramuscularly (Hoechst, 227 
Marion Roussel, Madrid, Spain). Synchronous females were anaesthetised by 228 
intramuscular injection of 16 mg of xylazine (Rompún, Bayer AG, Leverkusen, 229 
Germany) following intravenous injection of 16-20 mg ketamine hydrochloride 230 
(Imalgène, Merial SA, Lyon, France). Oviductal embryo transfer was performed using 231 
the laparoscopic technique described by Besenfelder and Brem (1993). The number of 232 
embryos transferred per recipient doe was from 12 to 15. At the end of the transfer, 233 
rabbit does were intramuscularly injected with 0.5 mL/doe of enrofloxacin (Baytril 5%, 234 
Bayer, Barcelona, Spain), brought back to the flat deck cages and fed a standard pellet 235 
diet ad libitum, having free access to water.  236 
Embryo survival rate  237 
Eleven days after ovulation induction, laparoscopy was performed on the recipient does 238 
and the number of implanted embryos per female was recorded. Animals were 239 
anaesthetised as described above. In vivo implantation rate was calculated as the 240 
successful implantation of the total transferred embryos per each recipient. At birth, 241 
litter size and individual pup weight were recorded. Offspring rate at birth was defined 242 
as the number of pups at birth related to the number of transferred embryos. 243 
Statistical analysis 244 
For development to hatched blastocyst, implantation and offspring rates at birth, a probit 245 
link with binomial error distribution was used, including the treatment group as fixed 246 
effect. Data on relative mRNA abundance were analysed by ANOVA using a GLM 247 
including the treatment group as fixed effect. NANOG data were normalised by an 248 
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Arctangent transformation for its subsequent analysis. All statistical analyses were 249 
performed with SPSS software (SPSS 16.0 software package; SPSS Inc., 2002, 250 
Chicago, IL, USA). Results were reported as least-square means (LSM) with standard 251 
error of the mean. LSM were separated using Fisher’s protected least significant 252 
difference test, with treatment effect declared significant at P < 0.05. 253 
RESULTS 254 
Of the 890 vitrified embryos, 856 (96.1%) had no damage to their covers and were 255 
cultured or transferred. 256 
Effects of superstimulation treatment on in vitro development, implantation and 257 
offspring rates 258 
As shown in Table 2, In vitro development of vitrified embryos was not significantly 259 
affected by superstimulation with or without rhLH supplementation, resulting in similar 260 
development rates to those of the control groups (fresh and vitrified).  261 
The implantation and offspring rates at birth were negatively affected by 262 
superstimulation treatment supplemented with rhLH. Both rhFSH or CTP vitrified 263 
embryo groups showed an implantation rate similar to those of the vitrified and fresh 264 
control groups, but a survival rate at birth lower than the fresh control group (Table 2). 265 
Effects of superstimulation treatment on OCT4 and NANOG relative expression 266 
Blastocysts developed from vitrified embryos showed higher levels of OCT4 transcript 267 
abundance than fresh control, while NANOG transcript abundance was only higher in 268 
the blastocysts developed from vitrified embryos after superstimulation treatment, in 269 
comparison with the fresh and vitrified control groups (Table 2).  270 
 271 




This study showed that rabbit embryos derived from a long acting rhFSH (CTP) provide 273 
a cryosurvival similar to that of fresh embryos derived from unstimulated donors in 274 
terms of implantation rate and similar survival rate at birth to those of vitrified embryos 275 
derived from unstimulated donors. In addition, the results indicate that superovulation 276 
treatment with CTP provides similar cryosurvival to that found when daily rhFSH is 277 
administered. Therefore, our results showed that superovulation treatment using CTP is 278 
a successful strategy for the establishment of GRBs in rabbit, reducing the level of 279 
distress for the animal and making its application more practical and efficient (Viudes-280 
de-Castro et al., 2017). 281 
When CTP or rhFSH was supplemented with rhLH, implantation and offspring rate 282 
were lower. Nevertheless, no negative effects were detected either in the in vitro 283 
development or in the transcript abundance analysis of two candidate genes related to 284 
embryo development and cell pluripotentiality. The usual in vitro parameters to evaluate 285 
oocyte or embryo quality are based on morphological appearance at the recovery 286 
moment, development rate, metabolites and some gene expression levels such as factor 287 
octamer-binding 4 (OCT4), NANOG homeobox (NANOG) and SOX2, but they may 288 
not be enough. Changes in gene expression might trigger failures in development and 289 
implantation of the embryos and, consequently, in pregnancy loss. In this study, 72h 290 
superovulated vitrified embryos cultured for 48h had OCT4 and NANOG up-regulation 291 
versus non-superovulated fresh embryos, showing signs of alterations induced by 292 
vitrification process in these embryos, although no changes of in vitro developing rates 293 
were observed. These altered expressions were not observed when these genes were 294 
analysed in superovulated and non-superovulated fresh embryos (Viudes-de-Castro et 295 
al., 2017).  However, these results agree with the epigenetic changes in developing 296 
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vitrified mouse embryos at promoter region of three pluripotency genes, including OCT-297 
4, observed by Wang et al. (2010) and Zhao et al. (2012). Only vitrified embryos from 298 
non-superovulated donors did not have NANOG over-expressed. In any case, the in 299 
vitro results were indicative of OCT4 and NANOG disturbances and this could explain 300 
the minor viability at birth of the vitrified embryos versus fresh control embryos, but did 301 
not support the lower viability of vitrified embryos obtained from superstimulation 302 
treatment supplemented with rhLH. It has been demonstrated that in vitro culture 303 
systems do not mimic the uterine environment and in vitro developed embryos differ 304 
from their in vivo counterparts, even after vitrification (Corcoran et al., 2006; Saenz-de-305 
Juano et al., 2010, Asku et al., 2012, Marco-Jiménez et al., Vicente et al., 2013). 306 
Vitrification and transfer procedures provide a sub-optimal condition and stressful 307 
environments to which the embryos must adapt (Saenz-de-Juano et al., 2016). This 308 
could contribute to the embryo-foetal programming and have consequences even in the 309 
neonatal period or adulthood (Pluess and Belsky, 2011). Previous studies in rabbit 310 
revealed that vitrification causes developmental differences in gastrulation, expression 311 
gene and proteomic disturbances in placental tissues with consequences on foetal 312 
mortality and differences in postnatal growth patterns (Mocé et al, 2010, Vicente et al, 313 
2013, Saenz-de-Juano et al., 2014, 2015). The present study shows the difficulties of 314 
rabbit vitrified embryos in surviving until the end of gestation, but especially if embryos 315 
come from superstimulation treatment supplemented with rhLH. Some authors have 316 
shown beneficial effects of LH on ovarian response, oocyte maturation and in vivo 317 
survival (Sirard et al. 2006, Ruvolo et al. 2007, Viudes-de-Castro et al. 2015 and 2017 318 
in rabbit). Viudes-de-Castro et al. (2017) showed that fresh embryos obtained from 319 
donors superstimulated with CTP and supplemented with rhLH reached similar 320 
implantation and birth survival rates to those of control embryos, suggesting a greater 321 
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embryo competence to implant than the other superstimulated groups with rhFSH with 322 
or without LH supplementation. However, in the present study, when CTP+rhLH was 323 
associated with the cryopreservation process, the in vivo cryosurvival or offspring rate 324 
of vitrified embryos was lower than for CTP alone and the vitrified control group. In the 325 
same way, rhFSH+rhLH group showed these detrimental effects on in vivo 326 
cryosurvival.  327 
Taking into account the modifications in the expression of the genes and the highest 328 
percentage of implanted embryos observed after the transfer of vitrified embryos from 329 
CTP and rhFSH groups (66 and 73%), it will be necessary to define adequate 330 
asynchrony or the recipient doe strain in order to improve survival through the reduction 331 
of foetal losses. Marco-Jiménez et al (2013) observed a higher rate of embryos 332 
developed to term when 12h asynchrony between vitrified embryo and recipients was 333 
used. In this study, we decided to test the cryosurvival of superovulated rabbit embryos 334 
in a synchronic approach. 335 
In conclusion, our findings indicate that embryos produced using corifollitropin alpha 336 
superovulation treatment do not compromise the cryosurvival of vitrified embryos in the 337 
rabbit. In addition, the present study clearly highlights the negative effect of rhLH 338 
supplementation in rhFSH superstimulation treatment in terms of offspring at birth, 339 
whereas there was no effect on in vitro embryo developmental rates. Therefore, 340 
corifollitropin alpha is a successful strategy for the establishment of genetic resource 341 
banks in the rabbit, reducing the level of distress for the animal and making its 342 
application more practical and efficient. 343 
 344 
 345 
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temperatures. Zentralblatt für Veterinärmedizin. Reihe A 22(5), 414–26.  450 
Pluess, M., Belsky, J., 2011. Prenatal programming of postnatal plasticity?. Dev. 451 
Psychopathol. 23(1), 29-38 452 
Russell, R., 2005. The Three Rs: Past, Present and Future. Animal Welfare 14, 279–286. 453 
Ruvolo, G. et al., Ruvolo G, Bosco L, Pane A, Morici G, Cittadini E, Roccheri MC 2007. 454 
Lower apoptosis rate in human cumulus cells after administration of recombinant 455 
luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization 456 
procedures. Fertility and Sterility 87(3), 542–546.  457 
Accepted manuscript, doi: 10.1016/j.anireprosci.2018.03.034 
20 
 
Saenz-de-Juano, M., Peñaranda, D.S., Marco-Jimenez, F., Llobat, M.D., Vicente, J.S., 458 
2011. Differential mRNA Expression in Rabbit In vivo Pre-implantatory Embryos. 459 
Reprod. Domes. Anim. 46(4), 567–572.  460 
Saenz-De-Juano, M.D., Marco-Jimenez, F., Schmaltz-Panneau, B., Jimenez-Trigos, E., 461 
Viudes-de-Castro, M.P., Peñaranda, D.S., Jouneau, L., Lecardonnel, J., Lavara, R., 462 
Naturil-Alfonso, C., Duranthon, V., Vicente, J.S., 2014.  Vitrification alters rabbit foetal 463 
placenta at transcriptomic and proteomic level. Reproduction 147(6), 789–801.  464 
Saenz-de-Juano, M.D., Vicentte, J.S.,  Hollung, K., Marco-Jimenez, M., 2015. Effect of 465 
embryo vitrification on rabbit foetal placenta proteome during pregnancy. PLoS ONE 466 
10(4),1–15. 467 
Saenz-de-Juano, M.D., Marco-Jiménez, F., Vicente, J.S., 2016.Embryo transfer 468 
manipulation cause gene expression variation in blastocysts that disrupt implantation 469 
and offspring rates at birth in rabbit. Eur J Obstet Gynecol Reprod Biol. 207, 50-55. 470 
Salvetti, P., Theau-Clément, M., Beckers, J.F., Hurtaud, J., Guérin, P., Neto, V., Falières, 471 
J., Joly, T., 2007. Effect of the luteinizing hormone on embryo production in 472 
superovulated rabbit does. Theriogenology  67, 1185–1193. 473 
Schmidt, P.M. et al., 1992. Induced ovulation and adequate embryo recoveries in New 474 
Zealand white rabbits treated with a low PMSG/HCG dose or single, daily injections of 475 
FSH-P. Theriogenology 37(1), 293.  476 
Sirard, M.A., Richard, F., Blondin, P., Robert, C., 2006. Contribution of the oocyte to 477 
embryo quality. Theriogenology 65(1), 126–136. 478 
Accepted manuscript, doi: 10.1016/j.anireprosci.2018.03.034 
21 
 
Takeo, T., Nakagata, N., 2015. Superovulation using the combined administration of 479 
inhibin antiserum and equine chorionic gonadotropin increases the number of ovulated 480 
oocytes in C57BL/6 female mice. PLoS One 10, e0128330. 481 
Taneja, M., Pareek, P.K., Jatkar, P.R., 1990. Superovulation and embryo recovery in 482 
rabbits (Oryctolagus cuniculus) using different doses of pregnant mare serum 483 
gonadotrophin (PMSG). Indian Journal of Experimental Biology 28(11), 1031–1033.  484 
Vajta, G., 2000. Vitrification of the oocytes and embryos of domestic animals. Anim. 485 
Reprod. Sci. 60-61, 357–364. 486 
Vicente, J.S., Viudes-de-Castro, M.P., García, M.L. 1999. In vivo survival rate of rabbit 487 
morulae after vitrification in a medium without serum protein. Reprod. Nutr. Dev. 39, 488 
657-662. 489 
Vicente, J.S., Saenz-de-Juano, M.D., Jiménez-Trigos, E., Viudes-de-Castro, M.P., 490 
Peñaranda, D.S., Marco-Jiménez, F. 2013. Rabbit morula vitrification reduces early 491 
foetal growth and increases losses throughout gestation. Cryobiology 67(3), 321–326. 492 
Viudes-de-Castro, M.P.; Pomares A., M D Saenz-de-Juano i Ribes, M.D., Marco-493 
Jiménez, F., Vicente, J.S., 2015. Effect of luteinizing hormone on rabbit ovarian 494 
superstimulation and embryo developmental potential. Theriogenology 84(3), 446–451. 495 
Viudes-de-Castro, M.P., Marco-Jimenez, F., Cedano-Castro, J.I., Vicente, J.S., 2017. 496 
Effect of corifollitropin alfa supplemented with or without LH on ovarian stimulation 497 
and embryo viability in rabbit. Theriogenology 98, 68-74.  498 
Wang, X., Dai, J., 2010. Concise Review: Isoforms of OCT4 Contribute to the 499 
Confusing Diversity in Stem Cell Stem. Cells 28(5), 885–893. 500 
Accepted manuscript, doi: 10.1016/j.anireprosci.2018.03.034 
22 
 
Zhao, X.M., Du, W.H., Hao, H.S., Wang, D., Qin, T., Liu, Y., Zhu, H.B., 2012. Effect of 501 
vitrification on promoter methylation and the expression of pluripotency and 502 
differentiation genes in mouse blastocysts. Mol. Reprod. Dev. 79(7), 445–450.  503 
504 




Figure 1.   Non-developed morula (A), hatching (B) and hatched (C) rabbit blastocyst 506 
embryos after 48h of in vitro culture 507 
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Table 1. List of primers used for quantitative real-time polymerase chain reaction.        508 
Gene symbol Forward primer Reverse primer Fragment (bp) 
OCT4 CGAGTGAGAGGCAACTTGG CGGTTACAGAACCACACACG 125 
NANOG CCAGGTGCCTCTTACAGACA TCACTACTCTGGGACTGGGA 104 
H2AFZ AGAGCCGGCTGCCAGTTCC CAGTCGCGCCCACACGTCC 85 
GAPDH GCCGCTTCTTCTCGTGCAG ATGGATCATTGATGGCGACAACAT 144 
    509 
H2AFZ: H2A histone family member Z; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase;  510 
OCT4: transcription factor octamer-binding 4; NANOG: NANOG homeobox. 511 
 512 
513 
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Table 2. Effect of ovarian stimulation treatments on in vitro and in vivo development (least square mean ± standard error). 514 





N CE Hatched 
blastocyst rate 
OCT4  NANOG TE Implantation 
rate 
Offspring 
rate at birth 
Vitrified 
FSH-CTP 165 82 0.55 ± 0.06 0.87 ± 0.083a  0.55 ± 0.084a 83 0.66 ± 0.05ab 0.48 ± 0.06b 
FSH-CTP+LH 176 95 0.48 ± 0.05 0.85 ± 0.083a  0.54 ± 0.084a 81 0.38 ± 0.05c 0.33 ± 0.05c 
FSH 175 98 0.60 ± 0.05 0.79 ± 0.083a  0.62 ± 0.084a 77 0.73 ± 0.05a 0.53 ± 0.06b 
FSH+LH 176 87 0.46 ± 0.05 0.76 ± 0.083a  0.54 ± 0.084a 89 0.42 ± 0.05c 0.31± 0.05c 
Non-superovulated 164 86 0.42 ± 0.05 0.73 ± 0.083a  0.23 ± 0.084b 78 0.53 ± 0.06bc 0.44 ± 0.06bc 
Fresh Non-superovulated 171 88 0.57 ± 0.05 0.48 ± 0.083b  0.28 ± 0.084b 83 0.78 ± 0.05a 0.75 ± 0.05a 
CTP: Corifollitropin  single-injection; CTP+rhLH: A single-injection of corifollitropin  and five equal doses at 12-hours interval of 515 
recombinant human LH; rhFSH: Five equal doses at 12-hour intervals of recombinant human FSH. rhFSH+rhLH: Five equal doses at 12-hours 516 
interval of recombinant human FSH plus recombinant human LH; Non-superovulated group: Five doses at 12-hours interval of saline solution; 517 
N: Number of embryos; CE: Number of cultured embryos; TE: Number of transferred embryos. a,bValues in the same column with different 518 
superscripts are statistically different (P<0.05). 519 
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